Skip to main content
. 2020 Jun 7;26(21):2877–2888. doi: 10.3748/wjg.v26.i21.2877

Table 1.

Patient demographics, n = 89

Variables Value
Gender, n (%)
Male 51 (57.3)
Female 38 (42.7)
Age in yr, mean ± SD 54.4 ± 10.1
BMI in kg/m2, mean ± SD 24.9 ± 4.6
ASA score, n (%)
ASA I 13 (14.6)
ASA II 56 (62.9)
ASA III 20 (22.5)
cT stage
cT3 54 (60.7)
cT4 35 (39.3)
cN stage
N1 50 (56.2)
N2 39 (43.8)
Neoadjuvant chemoradiotherapy
No 26 (29.2)
Short-course radiotherapy 3 (3.4)
Long-course radiotherapy + chemotherapy 60 (67.4)

ASA: American Society of Anesthesiologists; BMI: Body mass index; SD: Standard deviation.